Author

Ying Du

Primary ORCID profile (0009-0002-2223-6076 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ying DuiD1 paper · University of Saskatchewan

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Fang HeiD· 1 shared Hui XiongiD· 1 shared Jianhua WangiD· 1 shared Juan Xu· 1 shared Jun LiiD· 1 shared Lina ZhuiD· 1 shared Qiuping LiiD· 1 shared Ruijie Gu· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Fang HeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

First-in-human case report: AAV9-hGAA gene therapy for a patient with infantile-onset Pompe disease.

Xiuwei Ma, Jun Li, Xiaodong Wang, Wenhao Ma, Jianhua Wang, Ruijie Gu, Zhiming Zhu, Yongxia Wang, Ying Du, Juan Xu, Fang He, Xiao Yang, Sheng Zhang, Lina Zhu, Qiuping Li, , Zhichun Feng

A single intravenous dose of AAV9-hGAA gene therapy improved motor milestones and GAA enzyme activity in an infant with infantile-onset Pompe disease.

medRxiv · Dec 22, 2022 · PreprintGenetic & Genomic Medicine